A Synthetic Receptor Enables Breakthrough Scale Manufacturing of iPSC-Derived CD19-CAR Cell Therapies for Hematologic and Autoimmune Diseases
Dillon K. Jarrell, Samantha Ohara, Igor I. Slukvin(University of Wisconsin–Madison), Ryan Larson(CTI BioPharma (United States)), Cassidy Arnold, Andrew M. Scharenberg(CTI BioPharma (Italy)), Ryan Koning, David Vereide, Ashley Yingst, Ryan Crisman, Max Murphey, Nikole Perdue
Cited by 0
Related Papers
ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology
|Nature|2001|897
TRPM4 Is a Ca2+-Activated Nonselective Cation Channel Mediating Cell Membrane Depolarization
|Cell|2002|751
A Unified Nomenclature for the Superfamily of TRP Cation Channels
|Molecular Cell|2002|679